•Senators Elizabeth Warren and Richard Blumenthal asked the SEC to investigate whether the TRUMP token illegally facilitated fraud or a 'soft rug pull'.
•The token's market cap fell from a $9 billion peak to below $400 million, with investors losing approximately $3.8 billion.
•A securities fraud class action lawsuit was filed against Regeneron for allegedly misleading investors about Phase III Fianlimab-Libtayo trial success.
•Clinical trials failed to achieve statistical significance for the primary endpoint, leading to a 9% drop in stock price.
